News
18.09.2024
RIA / IRMA Diagnostic Solutions at Medipan
Discover our products of the line RIA and IRMA
More details
13.05.2024
Investing in the future of diagnostics
GA Generic Assays receives funding from the Just Transition Fund (JTF) We are very pleased that GA Generic Assays has received funding from the Just Transition Fund (JTF) for the expansion of our existing facility. The aim of this project is to expand our production of immunological test kits for the serological diagnosis of autoimmune […]
More details
26.04.2024
New Blot GAlaxy Software
GA Generic Assays’ New Blot GAlaxy Software We are excited to introduce the Blot Galaxy Software, the latest innovation from GA Generic Assays in immunoblot analysis. This advanced software represents a significant step forward in laboratory technology, providing accuracy, efficiency, and reliability for modern diagnostic laboratories. The Blot Galaxy Software has been carefully developed to […]
More details
17.04.2024
New ISO 13485 Certificates for Medipan & GA
New ISO 13485 Certificates for Medipan & GA Generic Assays We are delighted to announce an important milestone for our organizations: Medipan GmbH and GA Generic Assays GmbH have both successfully obtained new TÜV certificates for their quality management systems. These certificates were issued by TÜV Rheinland LGA Products GmbH in accordance with the international […]
More details
12.04.2023
Anti-CCP ELISA Test
Anti-CCP IgG Enzyme Immunoassay (REF 3665) The Anti-CCP IgG Enzyme Immunoassay is a reliable diagnostic test used for the quantitative detection of IgG antibodies against cyclic citrullinated peptides (CCP) in human serum. These antibodies are considered highly specific markers for rheumatoid arthritis. Therefore, anti-CCP testing plays an important role in early diagnosis and clinical decision-making. […]
More details